1,011 followers
@knack @janrosieratucd #geneesmiddelenprijs @pharmabe - "Treatment with cabozantinib more effective than treatment with axitinib or everolimus but associated higher total costs" $US197,089 vs. $US163,902 https://t.co/s7MZv9BdkZ + https://t.co/mpHvisFNXc